Bridgefront Capital’s Agilon Health AGL Stock Holding History
Bought
Maintained
Sold
Other funds holding AGL
CDR
RSCM
Bridgefront Capital's AGL Position: Q3 2024 in Review
Bridgefront Capital sold out of Agilon Health (AGL) in Q3 2024, closing a stake of 616 shares — an estimated $101K sold.
Bridgefront Capital first reported a position in AGL in Q1 2022 and held it in 3 quarters. The position peaked at $212K in Q1 2022. 209 funds tracked by Wall St. Rank hold AGL as of Q3 2024.
- Bridgefront Capital reported no remaining Agilon Health position as of Q3 2024 after selling out during the quarter.
- Bridgefront Capital sold 616 Agilon Health shares in Q3 2024, an estimated $101K.
- Bridgefront Capital first reported a position in Agilon Health in Q1 2022 and held it in 3 quarters.
- Bridgefront Capital's Agilon Health position peaked at $212K in Q1 2022.
- 209 funds tracked by Wall St. Rank held Agilon Health as of Q3 2024.
Based on Bridgefront Capital's 13F filing for Q3 2024, filed 14 Nov 2024.